The substrate binding site of ecNadD (Zhang, et al., 2002) was selected as the target for docking. Visual inspection of the binding region, solvent accessibility calculations along with consideration of sequence conservation led to the selection of residues Phe8, His19, Ile105 and Ile106 to define the putative inhibitor binding site. In addition, the level of sequence conservation between the bacterial and human enzymes in this region is low, thereby maximizing the potential that inhibitors specific for bacterial NaMNAT may be identified. The apo ecNadD structure (pdb 1k4k) was used for the primary screen as it represents a more open form of the binding pocket compared to the product deamido-NAD bound form. Molecular modeling and dynamics calculations were undertaken to prepare the protein structures for screening. All modeling calculations were performed with the program CHARMM (Brooks, et al., 1983; MacKerell, 1998) using the CHARMM22 all-atom protein force field and the TIP3P water model (Jorgensen, et al., 1983). In the case of the crystallographic structures in 1k4k the sidechain of Trp117 partially blocks the targeted binding side. Therefore, the conformation of sidechain was searched by performing a two-dimensional χ1, χ2 dihedral energy surface. Following reading of the structures of monomers A, C and D from 1k4k into CHARMM and adding hydrogens via the IC utility, the energy surfaces were performed by constraining the remainder of the protein structure and systematically sampling χ1 and χ2 in 15 degree increments with an energy minimization to an RMS gradient < 10 -4 kcal/mol/Å at each step in the surface. From the resulting energy surfaces the lowest energy conformation of the residue was obtained and used for docking. For all three monomers the resulting conformation was such that the Trp117 sidechain did not block the binding site. The resulting conformation of monomer A of 1k4k was used for the primary screen of ~1 million compounds with those for monomers A, C and D used in secondary screen one. Additional conformations of the protein for use in secondary screen two was generated by MD simulation. System preparation for the simulation involved obtaining the A monomer of 1k4k, building hydrogens based on the IC facility in CHARMM followed by a 500 step Steepest Descent energy minimization with the protein non-hydrogen atoms harmonically restrained with a mass weighted force constant of 1. The system was then overlaid with a preequilibrated box of water designed to be a minimum of 8 Å larger than the protein in the X, Y and Z directions. Water molecules with the oxygen atom within 2.5 Å of any protein non-hydrogen atom were deleted. The system was then minimized for 500 SD steps with the protein harmonically restrained, as above, followed by an additional 500 step SD minimization of the entire system. The MD simulation was initiated from the minimized structure using the Leapfrog integrator in the isothermic, isobaric (NPT) ensemble (Feller, et al., 1995) with an integration timestep of 2 fs and SHAKE (Ryckaert, et al., 1977) of all covalent bonds involving hydrogens. Nonbond
Comparison of primary screening results for E. coli and B. anthracis NadDs
Comparison of two sets of 10 % (38) top-ranking ecNadD and baNadD inhibitors revealed as many as 12 matches. The large number of shared compounds points to a strong correlation between the two datasets. Indeed, the estimated probability to randomly get at least 12 matches is equal to 3·10 -12 . Such probability (p) was calculated as follows: where A is the number of unique 38-compounds sets having at least 12-compounds matches to a given 38-compounds set, B is the number of all possible unique 38-compounds sets, where K sz is the size of the sample set (38), K mt is the number of matches (12) , and N is the total number of compounds (307).
Computational analysis of inhibitor selectivity
Docking of selected compounds from Table S2 (some of which included in Table 2 ) was performed targeting the binding region into which compound 3_02 was observed to bind in the crystal structure. Docking targeted all available crystal structures of the E. coli NadD (n=2, pdb codes 1k4k and 1k4m (Zhang, et al., 2002) ), B. anthracis NadD (n=5, 2qtm, 2qtn, 2qtr, 3dv2, and 3e27[13, 14] ) and human NMNAT-1 (n=4, 1kku, 1kqn, 1kqo, 1kr2(Garavaglia, et al., 2002; Zhou, et al., 2002) ) (Table A) . Sphere sets to direct docking were generated using the SPHGEN, selecting sphere sets located in the binding region defined by 3_02 in the crystal structures. Residues adjacent to the sphere sets are listed in Table A below. Docking was performed for each compound against each crystal structure using the secondary screening approach. The most favorable Dock energy scores for each compound over all the crystal structures for each of the three species are listed in Table B . With respect to the E. coli and B. anthracis enzymes there is no appreciable correlation with the IC 50 values reported in Table S2 . For example, the IC 50 values of 1_02 are similar, while docking predicts binding to ecNadD to be favored while with 3_23 the more favorable energy with the baNadD is consistent with the relative IC 50 values. An interesting outcome of the docking is that a larger number of the compounds have docking energies that are more favorable with baNadD then with ecNadD (9 versus 6, respectively). This may indicate that while docking was performed targeting ecNadD, there is some inherent property of baNadD that leads to favorable ligand-protein interactions. However, this result may be due to the docking analysis being performed against 5 conformations of baNadD versus 2 for ecNadD, where the larger number of conformations increases the probability that a conformation more suitable for a given ligand is targeted. Perhaps more significant are the results when the docking energies are compared for all three species. For all but two of the 15 compounds the least favorable score occurs with hsNMNAT, with the most favorable score occurring for only one compound (3_05). To better understand the types of interactions leading to the less favorable scores with hsNMNAT, the electrostatic and vdW ligand-protein interaction energies were examined. Results in Table C show the most favorable electrostatic interaction energies to often occur with the human enzyme while the most unfavorable most often occur with ecNadD. In contrast with the vdW energy, in the majority of cases the human enzyme term is the least favorable, with only two exceptions. To more closely examine the nature of the vdW contribution the attractive vdW interaction energy was calculated. The attractive vdW interaction represents the quality of the steric fit of a ligand with the protein, such that it is used as the compound scoring criteria for the primary screen methodology in this study. Results in Table D show that hsNMNAT has the least favorable attractive vdW interaction energy in all but one case. Although the docking approaches and scoring functions used in the analysis are very approximate, the observed vdW terms were consistently most unfavorable for hsNMNAT suggesting that the overall shape of the binding region of the human enzyme differs enough from that of ecNadD and baNadD to afford the observed selective inhibition. The attractive vdW results show baNadD to typically have the most favorable values. Values are based on the most favorable electrostatic or vdW energy for each compound over the crystal structures used for docking for each species. Energies are in kcal/mol. Most favorable energy for each compound is highlighted in yellow and the least favorable in blue. Values are based on the most favorable attractive vdW energy for each compound over the crystal structures used for docking for each species. Energies are in kcal/mol. Most favorable energy for each compound is highlighted in yellow and the least favorable in blue. divergent. hsNMNAT-1 residues corresponding to baNadD W116 and Y112 (W169 and S162, shown in thin blue line in B would clash with the inhibitor in its present pose. The docking pose of 3_02 is shown as thick sticks while the observed pose in the cocrystal structure is shown as ball-and-sticks. The red spheres defined the region that was targeted during the in silico database screen. The conformational flexibility and observed hand-shake dimer formation in the crystal likely contributed to the difference in the two poses. subtilis) model species is reflected by the background color of the cells in the columns marked ecNadD and baNadD, respectively. Background colors reflect the extent of growthsuppression ranging from strong" (40-100%; light orange) to "weak" (5-40%; grey). White background corresponds to no significant antibacterial activity (<5%). Growth suppression was assessed by AUGC (area under the growth curve) method. For E. coli strain (∆nadA) the growth tests were performed in the presence of 100 µM inhibitors, and the AUGC was determined in a stationary phase (35 hrs). For B. subtilis the AUGC measurements was performed in mid log-phase after 4 hrs growth in the presence of 50 µM compounds. Additionally, MIC 50 values were determined for most active compounds (3_05, 3_15, 3_17, 3_23, and 1_03) for both B. anthracis sterne and B. subtilis (see Table 2 ).
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